Application Sponsors
| ANDA 091032 | HIKMA FARMACEUTICA |  | 
Marketing Status
| Prescription | 001 | 
| Prescription | 002 | 
Application Products
| 001 | INJECTABLE;INJECTION | 40MG/2ML (20MG/ML) | 0 | IRINOTECAN HYDROCHLORIDE | IRINOTECAN HYDROCHLORIDE | 
| 002 | INJECTABLE;INJECTION | 100MG/5ML (20MG/ML) | 0 | IRINOTECAN HYDROCHLORIDE | IRINOTECAN HYDROCHLORIDE | 
FDA Submissions
 | ORIG | 1 | AP | 2010-12-20 |   | 
| LABELING; Labeling | SUPPL | 3 | AP | 2015-01-02 | STANDARD  | 
Submissions Property Types
TE Codes
| 001 | Prescription | AP | 
| 002 | Prescription | AP | 
CDER Filings
HIKMA FARMACEUTICA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91032
            [companyName] => HIKMA FARMACEUTICA
            [docInserts] => ["",""]
            [products] => [{"drugName":"IRINOTECAN HYDROCHLORIDE","activeIngredients":"IRINOTECAN HYDROCHLORIDE","strength":"40MG\/2ML (20MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"IRINOTECAN HYDROCHLORIDE","activeIngredients":"IRINOTECAN HYDROCHLORIDE","strength":"100MG\/5ML (20MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"IRINOTECAN HYDROCHLORIDE","submission":"IRINOTECAN HYDROCHLORIDE","actionType":"40MG\/2ML (20MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"IRINOTECAN HYDROCHLORIDE","submission":"IRINOTECAN HYDROCHLORIDE","actionType":"100MG\/5ML (20MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )
)